Biblio
Export 165 results:
Author Title Type [ Year] Filters: First Letter Of Last Name is X [Clear All Filters]
“Gut Microbiome Features of Chinese Patients Newly Diagnosed with Alzheimer's Disease or Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 80, no. 1, pp. 299-310, 2021.
, “High Fat Diet Mediates Amyloid-β Cleaving Enzyme 1 Phosphorylation and SUMOylation, Enhancing Cognitive Impairment in APP/PS1 Mice.”, J Alzheimers Dis, vol. 85, no. 2, pp. 863-876, 2021.
, “Loneliness, Not Social Support, Is Associated with Cognitive Decline and Dementia Across Two Longitudinal Population-Based Cohorts.”, J Alzheimers Dis, vol. 85, no. 1, pp. 295-308, 2021.
, “Lung Function Impairment and the Risk of Incident Dementia: The Rotterdam Study.”, J Alzheimers Dis, vol. 82, no. 2, pp. 621-630, 2021.
, “Mortality After Ischemic Stroke in Patients with Alzheimer's Disease Dementia and Other Dementia Disorders.”, J Alzheimers Dis, vol. 81, no. 3, pp. 1253-1261, 2021.
, “The Retinal Vessel Density Can Reflect Cognitive Function in Patients with Alzheimer's Disease: Evidence from Optical Coherence Tomography Angiography.”, J Alzheimers Dis, vol. 79, no. 3, pp. 1307-1316, 2021.
, “Serum Uric Acid May Aggravate Alzheimer's Disease Risk by Affecting Amyloidosis in Cognitively Intact Older Adults: The CABLE Study.”, J Alzheimers Dis, vol. 81, no. 1, pp. 389-401, 2021.
, “Sustained Hippocampal Neural Plasticity Questions the Reproducibility of an Amyloid-β-Induced Alzheimer's Disease Model.”, J Alzheimers Dis, vol. 82, no. 3, pp. 1183-1202, 2021.
, “Comorbidity of Cerebrovascular and Alzheimer's Disease in Aging.”, J Alzheimers Dis, vol. 78, no. 1, pp. 321-334, 2020.
, “Exploration of Plasma Lipids in Mild Cognitive Impairment due to Alzheimer's Disease.”, J Alzheimers Dis, vol. 77, no. 3, pp. 1117-1127, 2020.
, “Glucose Fluctuations Are Linked to Disrupted Brain Functional Architecture and Cognitive Impairment.”, J Alzheimers Dis, vol. 74, no. 2, 2020.
, “Influence of Comorbidity of Cerebrovascular Disease and Amyloid-β on Alzheimer's Disease.”, J Alzheimers Dis, vol. 73, no. 3, pp. 897-907, 2020.
, “The Prevalence of Dementia: A Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 73, no. 3, pp. 1157-1166, 2020.
, “Resilience of Alzheimer's Disease to COVID-19.”, J Alzheimers Dis, vol. 77, no. 1, pp. 67-73, 2020.
, “Vascular Risk Factors and Alzheimer's Disease: Blood-Brain Barrier Disruption, Metabolic Syndromes, and Molecular Links.”, J Alzheimers Dis, vol. 73, no. 1, pp. 39-58, 2020.
, “Association of Cognitive Function with Amyloid-β and Tau Proteins in the Vitreous Humor.”, J Alzheimers Dis, vol. 68, no. 4, pp. 1429-1438, 2019.
, “A Brief Ischemic Postconditioning Protects Against Amyloid-β Peptide Neurotoxicity by Downregulating MLK3-MKK3/6-P38MAPK Signal in Rat Hippocampus.”, J Alzheimers Dis, vol. 71, no. 2, pp. 671-684, 2019.
, “Gut Microbiota Alteration and Its Time Course in a Tauopathy Mouse Model.”, J Alzheimers Dis, vol. 70, no. 2, pp. 399-412, 2019.
, “Neuron-Specific Apolipoprotein E4 (1-272) Fragment Induces Tau Hyperphosphorylation and Axonopathy via Triggering Endoplasmic Reticulum Stress.”, J Alzheimers Dis, vol. 71, no. 2, pp. 597-611, 2019.
, “Small Molecule Amyloid-β Protein Precursor Processing Modulators Lower Amyloid-β Peptide Levels via cKit Signaling.”, J Alzheimers Dis, vol. 67, no. 3, pp. 1089-1106, 2019.
, “An UNC5C Allele Predicts Cognitive Decline and Hippocampal Atrophy in Clinically Normal Older Adults.”, J Alzheimers Dis, vol. 68, no. 3, pp. 1161-1170, 2019.
, “Abnormal Functional Brain Networks in Mild Cognitive Impairment and Alzheimer's Disease: A Minimum Spanning Tree Analysis.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1093-1107, 2018.
, “Alzheimer's Disease rs11767557 Variant Regulates EPHA1 Gene Expression Specifically in Human Whole Blood.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1077-1088, 2018.
, “Amyloid-β25-35 Upregulates Endogenous Neuroprotectant Neuroglobin via NFκB Activation in vitro.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1163-1174, 2018.
, “Amyloid-β25-35 Upregulates Endogenous Neuroprotectant Neuroglobin via NFκB Activation in vitro.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1163-1174, 2018.
,